Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Preference Study With Elderly Patients Recurrent Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				70 and over				Other				3401000 NCT00170690


2.		Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 to 65				Other				OSHO #071 NCT00384553


3.		MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 65				Other				2003.332 NCT00129155

Last Modified: 7/11/2007 First Published: 11/4/2005


4.		Phase II Study of a Reduced-Intensity Conditioning Regimen Comprising Treosulfan and Fludarabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				60 and under				NCI, Pharmaceutical / Industry				FHCRC-1931.00 MEDAC-FHCRC-1931.00, NCT00253513, OHSU-HEM-05107-LM


5.		Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-Refractory Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				CSTI571BDE59 NCT00427999


6.		Treosulfan-Based Conditioning for Transplantation in AML/MDS

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 68				Other				SHEBA-07-3116-AN-CTIL NCT00491634


7.		Study of Metastatic Ocular Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				Haema CBF AHM UK/AS 04 NCT00168870


8.		Clinical Phase II Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 69				Other				2005-005182-11 NCT00598624


9.		Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 65				Other				TreoALL NCT00682305

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute